Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Pharmaceuticals (Basel, Switzerland)|March 28, 2024
The Current Therapeutic Landscape for Metastatic Prostate CancerAnastasia Bernal, Alivia Jane Bechler, Kabhilan Mohan, et al.
Data in Brief|September 5, 2020
Imaging data on characterization of retinal autofluorescent lesions in a mouse model of juvenile neuronal ceroid lipofuscinosis (CLN3 disease)Qing Jun Wang, Kyung Sik Jung, Kabhilan Mohan, et al.
Investigative Ophthalmology & Visual Science|April 27, 2013
Retinal ganglion cell damage in an experimental rodent model of blast-mediated traumatic brain injuryKabhilan Mohan, Helga Kecova, Elena Hernandez-Merino, et al.
Veterinary Ophthalmology|August 16, 2018
Optical coherence tomography and molecular analysis of sudden acquired retinal degeneration syndrome (SARDS) eyes suggests the immune-mediated nature of retinal damageSinisa D Grozdanic, Tatjana Lazic, Helga Kecova, et al.
Veterinary Ophthalmology|December 28, 2020
Presumed cancer-associated retinopathy (CAR) mimicking Sudden Acquired Retinal Degeneration Syndrome (SARDS) in caninesSinisa D Grozdanic, Tatjana Lazic, Helga Kecova, et al.
Veterinary Ophthalmology|May 31, 2012
Characterization of structure and function of the mouse retina using pattern electroretinography, pupil light reflex, and optical coherence tomographyKabhilan Mohan, Matthew M Harper, Helga Kecova, et al.
International Journal of Molecular Sciences|March 29, 2023
Long-Term Evaluation of Retinal Morphology and Function in Rosa26-Cas9 Knock-In MiceKabhilan Mohan, Sushil Kumar Dubey, Kyungsik Jung, et al.
Investigative Ophthalmology & Visual Science|February 14, 2012
Topical ocular sodium 4-phenylbutyrate rescues glaucoma in a myocilin mouse model of primary open-angle glaucomaGulab S Zode, Kevin E Bugge, Kabhilan Mohan, et al.
The Journal of Clinical Investigation|August 9, 2011
Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucomaGulab S Zode, Markus H Kuehn, Darryl Y Nishimura, et al.
Hemato|October 25, 2024
The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or VenetoclaxAlexandria P Eiken, Elizabeth Schmitz, Erin M Drengler, et al.
Pageof 2